Prestige Consumer Healthcare
PBH
#3928
Rank
S$3.77 B
Marketcap
S$78.59
Share price
-0.89%
Change (1 day)
-28.86%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): S$5.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is S$5.20. In 2024 the company made an earnings per share (EPS) of S$5.51 an increase over its 2023 EPS that were of S-$2.06.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$5.36-2.72%
2024S$5.51-367.08%
2023S-$2.06-138.33%
2022S$5.3811.7%
2021S$4.8213.6%
2020S$4.24-651.67%
2019S-$0.77-148.78%
2018S$1.58-83.29%
2017S$9.43437.23%
2016S$1.75-34.13%
2015S$2.6652.94%
2014S$1.74-8.11%
2013S$1.90
2011S$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.27 174.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
S$8.85 70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.43 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.74-66.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.80-7.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
S$7.88 51.48%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
S$0.51-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.83-7.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
S-$37.94-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
S$1.56-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel